• 1
    Shih HI, Chuang YC, Cheung BM, et al. Sporadic and outbreak cases of melioidosis in southern Taiwan: clinical features and antimicrobial susceptibility. Infection 2009; 37:915.
  • 2
    Novak RT, Glass MB, Gee JE, et al. Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei. J Clin Microbiol 2006; 44:8590.
  • 3
    Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology and management. Clin Microbiol Rev 2005; 18:383416.
  • 4
    Puthucheary SD, Parasakthi N, Lee MK. Septicaemic melioidosis: a review of 50 cases from Malaysia. Trans R Soc Trop Med Hyg 1992; 86:683685.
  • 5
    Lim MK, Tan EH, Soh SC. Burkholderia pseudomallei infection in the Singapore arms forces from 1987-1994—an epidemiological review. Ann Acad Med Singapore 1997; 26:1317.
  • 6
    Currie BJ, Fisher DA, Howard DM, et al. Endemic melioidosis in tropical northern Australia: a ten year prospective study and review of the literature. Clin Inf Dis 2000; 31:981986.
  • 7
    Svensson E, Welinder-Olsson C, Claesson BA, Studahl M. Cutaneous melioidosis in a Swedish tourist after the tsunami in 2004. Scand J Infect Dis 2006; 38:7174.
  • 8
    Nieminen T, Vaara M. Burkholderia pseudomallei infections in Finnish tourists injured by the December 2004 tsunami in Thailand. Euro Surveill 2005; 10:E050303.4.
  • 9
    Badran S, Pedersen TI, Roed C, et al. Imported melioidosis in Danish travellers: a diagnostic challenge. Scand J Infect Dis 2010; 42:445449.
  • 10
    Currie BJ, Jacups SP, Cheng AC, et al. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop Med Int Health 2004; 9:11671174.
  • 11
    Ng CY, Leong EC, Chng HC. Ten-year series of splenic abscesses in a general hospital in Singapore. Ann Acad Med Singapore 2008; 37:749752.
  • 12
    Suputtamongkol Y, Chaowagul W, Chetchotisakd P, et al. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis 1999; 29:408413.
  • 13
    Holland DJ, Wesley A, Drincovic D, Currie BJ. Cystic fibrosis and Burkholderia pseudomallei infection: an emerging problem ? Clin Infect Dis 2002; 35:e138e140.
  • 14
    Heng BH, Goh KT, Yap EH, et al. Epidemiological surveillance of melioidosis in Singapore. Ann Acad Med Singapore 1998; 27:478484.
  • 15
    Peacock SJ, Schweizer HP, Dance DA, et al. Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg Infect Dis 2008; 14:e2.
  • 16
    Lowe P, Haswell H, Lewis K. Use of various common isolation media to evaluate the new VITEK 2 colorimetric GN card for identification of Burkholderia pseudomallei. J Clin Microbiol 2006; 44:854856.
  • 17
    Inglis TJ, Merritt A, Chidlow G, et al. Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei. J Clin Microbiol 2005; 43:22012206.
  • 18
    Lowe P, Engler C, Norton R. Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei. J Clin Microbiol 2002; 40:46254627.
  • 19
    Amornchai P, Chierakul W, Wuthiekanun V, et al. Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J Clin Microbiol 2007; 45:37743776.
  • 20
    Blaschitz M, Meidlinger L, Sagel U, et al. Detection of highly pathogenic bacteria by MALDI-TOF MS. Abstract P1773. ESCMID 2010.
  • 21
    Gee JE, Sacchi CT, Glass MB, et al. Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J Clin Microbiol 2003; 41:46474654.